South African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK variant


FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

South African variant may resist current antibody treatments

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Veteran volunteer digs for survivors after Colombia quake
Defense in Charlie Kirk case argues shooter should not face death penalty
Kennedy Center board decides to inscribe Trump's name on building despite judge order
U.S. stocks close higher
UN humanitarian chief fast-tracks funds for quake response in Colombia
1st LD: Two seriously injured after train derails in Southeast England
Kennedy Center board votes to inscribe Trump's name on building
Crude futures settle lower
U.S. dollar ticks down
Norwegian central bank holds key rate at 4.25 pct, keeps hike option open

Others Also Read